Samia Mora, MD, MHS
Associate Physician, Brigham and Women's Hospital
Assistant Professor of Medicine, Harvard Medical School
Contact information:
Office address:
Division of Preventive Medicine
900 Commonwealth Avenue East
Boston, Massachusetts 02215
Phone: 617-732-9300 (Clinic, patient care)
FAX: 617-264-9194
E-mail: smora2@partners.org
Primary research interests:
Cardiovascular disease prevention; clinical trials for the primary prevention of cardiovascular disease; exercise and exercise testing; role of lipoproteins and novel cardiac biomarkers in cardiovascular risk prediction.
Recent publications:
Mora S, Cook NR, Buring JE, Ridker PM, Lee IM. Physical activity and
reduced risk of cardiovascular events: potential mediating mechanisms.
Circulation 2007;116:2110-18.
Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC Jr, O'Leary
DH, Saad MF, Tsai MY, Sharrett AR. LDL particle subclasses, LDL particle size,
and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).
Atherosclerosis 2007;192:211-17.
Mora S, Zee RYL, Cheng S, Erlich HA, Lindpainter K, Rifai N, Buring JE,
Ridker PM. Homocysteine, 5, 10-methylenetetrahydrofolate reductase 677C>T
polymorphism, nutrient intake and incident cardiovascular disease in 24,968
initially healthy women. Clin Chem 2007; 53:845-51.
Mora S, Rifai N, Buring JE, Ridker PM. Additive value of immunoassay
measured fibrinogen and high-sensitivity C-reactive protein levels for
predicting incident cardiovascular events. Circulation 2006;114:381-87.
Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. Journal of the American Medical Association 2006; 295:1412-19.
Mora S, Ridker PM. The JUPITER Trial: Can C-reactive protein be used to target statin therapy in primary prevention? American Journal of Cardiology 2006; 97[suppl]:33A-41A.
Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced risk assessment in asymptomatic individuals using exercise testing and Framingham risk scores. Circulation 2005; 112:1566-72.
Mora S, Yanek LR, Moy TF, Fallin MD, Becker LC, Becker DM. Interaction of body mass index and Framingham risk score in predicting incident coronary disease in families. Circulation 2005;111:1871-6.
Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: A 20-year follow-up of the Lipid Research Clinics Prevalence Study. Journal of the American Medical Association 2003;290:1600-07.
Send Feedback to: 
